Under each [FactorName], explain the relationship of each factor with the price. [Underlying Stocks' Performance]: The primary driver is the performance of the pharmaceutical stocks it holds. If these companies (like Sun Pharma, Dr. Reddy's) perform well, the ETF's value rises, and vice-versa.

[NAV Movements]: The ETF's price closely tracks its Net Asset Value (NAV). Deviations may occur due to supply and demand, but generally, NAV fluctuations dictate price.

[Investor Sentiment]: Positive sentiment towards the Pharma sector (due to new drug approvals, increasing healthcare spending, etc.) boosts demand and price. Negative sentiment leads to price declines.

[Expense Ratio]: While a small impact, a higher expense ratio can slightly reduce returns over time compared to similar, lower-cost ETFs.

[Supply and Demand]: Increased demand (more buyers than sellers) drives the price up; increased supply (more sellers) pulls the price down, especially during periods of market volatility.

[Regulatory Changes]: New regulations affecting the pharmaceutical industry can impact the profitability of the underlying companies and, consequently, the ETF price.

[Global Economic Factors]: Broad economic trends, such as inflation or recession, can indirectly influence healthcare spending and impact pharmaceutical company revenues and the ETF's value.

[Currency Fluctuations]: Since some Pharma companies operate internationally, currency exchange rate movements can affect their reported earnings and, subsequently, the ETF price.

[Index Rebalancing]: Periodic rebalancing by the index provider could lead to buying or selling pressure on specific stocks, potentially affecting the ETF's price in the short term.

[Dividend Payments]: Dividends received from the underlying stocks are usually reinvested or distributed to ETF holders, which can positively influence the ETF's overall return and attractiveness.